EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
39 hedge funds and large institutions have $39.6M invested in Eiger BioPharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less capital invested
Capital invested by funds: $66.2M → $39.6M (-$26.7M)
Holders
39
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$400K | |
| 2 | +$365K | |
| 3 | +$316K | |
| 4 |
Goldman Sachs
New York
|
+$272K |
| 5 |
Renaissance Technologies
New York
|
+$185K |
Top Sellers
| 1 | -$4.06M | |
| 2 | -$3.02M | |
| 3 | -$1.23M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.06M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$472K |